The UK has left the EU and the transition period is set to come to an end on 31 December 2020. Government continues to consider what the final EU Exit arrangements might be.
DHSC has written to suppliers of medicines (4 August 2020 and 14 August 2020) setting out the Government’s preparations alongside its expectations of the industry in the run up to 31st December 2020. The letters mention the Reasonable Worst Case Scenario (RWCS) that Government is using. This includes a risk of significant disruption across the short straits for 6 months following the end of the transition period, with a particular risk during the first 3 months.
To combat this, suppliers are encouraged to review their own logistics arrangements and consider the appropriateness of using existing supply chain routes during this period. From the Government side, a 4-year procurement framework for freight capacity for ‘Category 1’ goods, which includes all health supplies, was initiated in 2019 and remains in place. DHSC has also retained its express freight service arrangements to support the urgent movement of medicines and medical products if other measures experience difficulties Full text is available below.
The fourth meeting of the Ireland/Northern Ireland Specialised Committee was held on 5 Nov 2020 via video conference and co-chaired by officials from the UK Government and the European Commission.
The UK and the EU exchanged updates on the implementation of the Protocol. The Committee noted that an agreed approach had been reached on a phased process for implementing medicines regulation in Northern Ireland up to 31 December 2021, providing the additional time needed for businesses to prepare in relation to batch testing, importation and Falsified Medicines Directive requirements. Full press is available below.
Correspondence and links
- The UK Transition
- Moving goods into, out of, or through NI from 1 January 2021 31 Dec 2020
- Supplying authorised medicines to NI from 1 January 2021 31 Dec 2020
- MHRA Brexit Transition: FAQs 21 Dec 2020
- EU Transition Stakeholder Briefing 8 Dec 2020
- CPNI CU 201208A re: Update on EU Transition – DoH Echo session 8 Dec 2020
- DoH (NI) EU Exit Operational Readiness Guidance 25 Nov 2020
- Press Release Ireland/ Northern Ireland Specialised Committee 5 Nov 2020
- CPNI CU 201103C re: EU Exit 3 Nov 2020
- Letter to medicine suppliers 3 Aug 2020
- EU Exit Letter from Cathy Harrison (CPO) to HSC organisations re: extension period next steps 21 Nov 2019
- Letter from Cathy Harrison (CPO) Continuity of Supply of Medicines and Medicinal Products into the UK 3 July 2019
Medicine shortages is a continuing issue with an increasing number of products being awarded a concessionary price. We appreciate the lengths contractors take to try to maintain medicine supply to patients but inevitably we know there are instances when not all medicines prescribed can be supplied at once.
CPNI has produced a standard patient leaflet to help contractors explain to patients the ongoing matter of medicine shortages.
Furthermore, CPNI has developed a Medicines Shortage Reporter to help contractors report problems experienced in obtaining medicines. This includes generic items and branded medicines.